Pd11-07 Integrated Results of Two Multicenter, Randomized, Placebo Controlled, Double Blind, Phase 3 Trials (Spi-611/612) of Single-Dose Intravesical Apaziquone Immediately Following Resection in Patients With Non-Muscle Invasive Bladder Cancer

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.847
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search